Show simple item record

dc.contributor.authorToldi, Gergely
dc.contributor.authorHummler, Helmut
dc.contributor.authorPillay, Thillagavathie
dc.date.accessioned2021-05-20T08:42:02Z
dc.date.available2021-05-20T08:42:02Z
dc.date.issued2021-06-08
dc.identifier.citationToldi G, Hummler H and Pillay T (2021) T Lymphocytes, Multi-Omic Interactions and Bronchopulmonary Dysplasia. Frontiers in Pediatrics. 9, Article Number 694034. doi: 10.3389/fped.2021.694034en
dc.identifier.issn2296-2360en
dc.identifier.doi10.3389/fped.2021.694034en
dc.identifier.urihttp://hdl.handle.net/2436/624069
dc.descriptionThis is an accepted manuscript of an article published by Frontiers Media in Frontiers in Pediatrics on 8 June 2021. The accepted version of the publication may differ from the final published version.en
dc.description.abstractBronchopulmonary dysplasia (BPD) remains a significant clinical challenge in neonatal medicine. BPD is clearly a multifactorial disease with numerous antenatal and postnatal components influencing lung development. Extremely immature infants are born in the late canalicular or early saccular stage and usually receive intensive care until the early alveolar stage of lung development, resulting in varying magnitudes of impairment of alveolar septation, lung fibrosis, and abnormal vascular development. The interactions between T lymphocytes, the genome and the epigenome, the microbiome and the metabolome, as well as nutrition and therapeutic interventions such as the exposure to oxygen, volutrauma, antibiotics, corticosteroids, caffeine and omeprazole, play an important role in pathogenesis and disease progression. While our general understanding of these interactions thanks to basic research is improving, this knowledge is yet to be translated into comprehensive prevention and clinical management strategies for the benefit of preterm infants developing BPD and later during infancy and childhood suffering from the disease itself and its sequelae. In this review, we summarise existing evidence on the interplay between T lymphocytes, lung multi-omics and currently used therapeutic interventions in BPD, and highlight avenues for potential future immunology related research in the field.en
dc.formatapplication/pdfen
dc.languageenglish
dc.language.isoenen
dc.publisherFrontiers Mediaen
dc.relation.urlhttps://www.frontiersin.org/articles/10.3389/fped.2021.694034/fullen
dc.subjectt lymphocyteen
dc.subjectneonateen
dc.subjectchronic lung diseaseen
dc.subjectbronchopulmonary dysplasiaen
dc.subjectimmunologyen
dc.titleT lymphocytes, multi-omic interactions and bronchopulmonary dysplasiaen
dc.typeJournal articleen
dc.identifier.journalFrontiers in Pediatricsen
dc.date.updated2021-05-18T20:33:46Z
dc.identifier.articlenumber694034
dc.date.accepted2021-05-18
rioxxterms.funderUniversity of Wolverhamptonen
rioxxterms.identifier.projectUOW20052021TPen
rioxxterms.versionVoRen
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/en
rioxxterms.licenseref.startdate2021-06-10en
refterms.dateFCD2021-05-20T08:38:46Z
refterms.versionFCDVoR
refterms.dateFOA2021-06-10T00:00:00Z


Files in this item

Thumbnail
Name:
Pillay_T_Lymphocytes_Multi_Omi ...
Size:
451.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/